EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-1.53%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.26B
AUM Growth
-$105M
(-7.7%)
Cap. Flow
-$59.3M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
60.92%
Holding
343
New
11
Increased
61
Reduced
233
Closed
34
Top Buys
| 1 |
Pinduoduo
PDD
|
$52.2M |
| 2 |
KE Holdings
BEKE
|
$28.2M |
| 3 |
TSMC
TSM
|
$11.8M |
| 4 |
Kanzhun
BZ
|
$5.71M |
| 5 |
iQIYI
IQ
|
$4.15M |
Top Sells
| 1 |
Tencent Music
TME
|
$38.3M |
| 2 |
Trip.com Group
TCOM
|
$19.3M |
| 3 |
Marvell Technology
MRVL
|
$14.8M |
| 4 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
$7.98M |
| 5 |
Microsoft
MSFT
|
$6.65M |
Sector Composition
| 1 | Consumer Discretionary | 37.28% |
| 2 | Technology | 32.43% |
| 3 | Communication Services | 9.6% |
| 4 | Healthcare | 8.37% |
| 5 | Real Estate | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
151
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $425K | 0.03% |
11,760
+1,913
| +19% | +$69.1K |
|
152
BioMarin Pharmaceuticals
BMRN
$11.1B
| $424K | 0.03% |
4,889
+621
| +15% | +$53.9K |
|
153
Protagonist Therapeutics
PTGX
$3.77B
| $424K | 0.03% |
15,354
+6,641
| +76% | +$183K |
|
154
Relay Therapeutics
RLAY
$710M
| $423K | 0.03% |
33,708
+8,516
| +34% | +$107K |
|
155
PTC Therapeutics
PTCT
$4.55B
| $422K | 0.03% |
10,387
+1,655
| +19% | +$67.2K |
|
156
Insmed
INSM
$30.7B
| $421K | 0.03% |
19,953
-1,526
| -7% | -$32.2K |
|
157
Intellia Therapeutics
NTLA
$1.29B
| $421K | 0.03% |
10,330
-452
| -4% | -$18.4K |
|
158
Abbott
ABT
$231B
| $417K | 0.03% |
3,826
-414
| -10% | -$45.1K |
|
159
Ironwood Pharmaceuticals
IRWD
$188M
| $415K | 0.03% |
38,989
+3,670
| +10% | +$39.1K |
|
160
Travere Therapeutics
TVTX
$1.93B
| $412K | 0.03% |
26,794
+8,262
| +45% | +$127K |
|
161
Vir Biotechnology
VIR
$732M
| $411K | 0.03% |
16,762
-319
| -2% | -$7.82K |
|
162
CRISPR Therapeutics
CRSP
$4.99B
| $409K | 0.03% |
7,294
-1,642
| -18% | -$92.1K |
|
163
89bio
ETNB
$1.32B
| $409K | 0.03% |
21,604
+3,464
| +19% | +$65.6K |
|
164
TG Therapeutics
TGTX
$5.11B
| $404K | 0.03% |
16,266
-11,162
| -41% | -$277K |
|
165
Enphase Energy
ENPH
$5.18B
| $401K | 0.03% |
2,395
-289
| -11% | -$48.4K |
|
166
Ultragenyx Pharmaceutical
RARE
$3.07B
| $401K | 0.03% |
8,693
-1,271
| -13% | -$58.6K |
|
167
Sarepta Therapeutics
SRPT
$1.96B
| $401K | 0.03% |
3,499
+815
| +30% | +$93.4K |
|
|
MORF
168
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $401K | 0.03% |
+6,991
| New | +$401K |
|
169
PACCAR
PCAR
$52B
| $400K | 0.03% |
4,776
-851
| -15% | -$71.3K |
|
170
Iovance Biotherapeutics
IOVA
$901M
| $399K | 0.03% |
56,609
-5,579
| -9% | -$39.3K |
|
171
Akero Therapeutics
AKRO
$3.58B
| $397K | 0.03% |
8,510
-830
| -9% | -$38.7K |
|
172
American Electric Power
AEP
$57.8B
| $396K | 0.03% |
4,705
-835
| -15% | -$70.3K |
|
173
Arista Networks
ANET
$180B
| $396K | 0.03% |
9,764
-924
| -9% | -$37.5K |
|
174
Airbnb
ABNB
$75.8B
| $395K | 0.03% |
3,080
-562
| -15% | -$72.1K |
|
175
Denali Therapeutics
DNLI
$2.26B
| $394K | 0.03% |
13,361
-1,258
| -9% | -$37.1K |
|